HK1223038A1 - 抗病毒有效的藥物組合物 - Google Patents

抗病毒有效的藥物組合物

Info

Publication number
HK1223038A1
HK1223038A1 HK16111405.8A HK16111405A HK1223038A1 HK 1223038 A1 HK1223038 A1 HK 1223038A1 HK 16111405 A HK16111405 A HK 16111405A HK 1223038 A1 HK1223038 A1 HK 1223038A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
effective pharmaceutical
virally effective
virally
composition
Prior art date
Application number
HK16111405.8A
Other languages
English (en)
Inventor
Sigurd Puetter
Richard Ammer
Michael Schmidbauer
Original Assignee
Medice Arzneimittel Puetter Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medice Arzneimittel Puetter Gmbh & Co Kg filed Critical Medice Arzneimittel Puetter Gmbh & Co Kg
Publication of HK1223038A1 publication Critical patent/HK1223038A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK16111405.8A 2013-06-28 2016-09-29 抗病毒有效的藥物組合物 HK1223038A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13174235.5A EP2818167A1 (de) 2013-06-28 2013-06-28 Antiviral wirksame pharmazeutische Zusammensetzung
PCT/EP2014/063671 WO2014207187A1 (de) 2013-06-28 2014-06-27 Antiviral wirksame pharmazeutische zusammensetzung

Publications (1)

Publication Number Publication Date
HK1223038A1 true HK1223038A1 (zh) 2017-07-21

Family

ID=48692374

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111405.8A HK1223038A1 (zh) 2013-06-28 2016-09-29 抗病毒有效的藥物組合物

Country Status (10)

Country Link
US (1) US9913861B2 (zh)
EP (2) EP2818167A1 (zh)
JP (1) JP2016523874A (zh)
CN (1) CN105451738B (zh)
AU (1) AU2014301029A1 (zh)
BR (1) BR112015031585A2 (zh)
HK (1) HK1223038A1 (zh)
RU (1) RU2657575C2 (zh)
WO (1) WO2014207187A1 (zh)
ZA (1) ZA201509091B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111991392A (zh) * 2020-09-10 2020-11-27 青岛大学附属医院 一种抗疱疹病毒感染的生物碱及其组合物与应用
CN114931647B (zh) * 2022-05-20 2023-10-13 浙江瑞瞳生物科技有限公司 一种用于治疗i型单纯疱疹病毒感染的外用药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874850A (en) * 1986-08-07 1989-10-17 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Pharmaceutical preparations
US4867107A (en) 1988-02-03 1989-09-19 Sullivan Engine Works, Inc. Rotary vee engine
RU2143917C1 (ru) * 1999-05-21 2000-01-10 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения гриппа и острых респираторных вирусных инфекций
US20020031509A1 (en) * 1999-12-28 2002-03-14 Bjorn Ortenheim Pharmaceutical composition and method for its manufacture
US8629283B2 (en) * 2008-03-06 2014-01-14 Icahn School Of Medicine At Mount Sinai Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof

Also Published As

Publication number Publication date
WO2014207187A1 (de) 2014-12-31
US20160143948A1 (en) 2016-05-26
CN105451738B (zh) 2018-05-18
AU2014301029A1 (en) 2016-01-21
US9913861B2 (en) 2018-03-13
ZA201509091B (en) 2016-11-30
RU2657575C2 (ru) 2018-06-14
EP2818167A1 (de) 2014-12-31
BR112015031585A2 (pt) 2017-07-25
EP3013343A1 (de) 2016-05-04
RU2016101929A (ru) 2017-07-26
JP2016523874A (ja) 2016-08-12
CN105451738A (zh) 2016-03-30
EP3013343B1 (de) 2018-08-08

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical preparations
SI3030262T1 (sl) Kombiniran farmacevtski sestavek
GB201322602D0 (en) Pharmaceutical compounds
PL2943181T3 (pl) Kompozycje farmaceutyczne
GB201306610D0 (en) Pharmaceutical compounds
ZA201408333B (en) Pharmaceutical compositions
HK1213182A1 (zh) 外用藥物組合物
EP2990038A4 (en) SOLID PHARMACEUTICAL COMPOSITION
IL244380A0 (en) Pharmaceutical compounds
SG11201601477VA (en) Pharmaceutical composition
GB201320932D0 (en) Topical pharmaceutical composition
GB201312386D0 (en) Pharmaceutical compounds
HRP20171888T1 (hr) Farmaceutski pripravci
HK1223038A1 (zh) 抗病毒有效的藥物組合物
HK1220143A1 (zh) 藥物組合物
GB201304699D0 (en) Pharmaceutical compositions
GB201321497D0 (en) Pharmaceutical compositions
GB201321316D0 (en) Pharmaceutical Compound
GB201304625D0 (en) New pharmaceutical composition
GB201312851D0 (en) Pharmaceutical compositions
GB201317166D0 (en) Pharmaceutical compounds
GB201316780D0 (en) Pharmaceutical compounds
GB201316791D0 (en) Pharmaceutical Compounds
GB201309405D0 (en) Pharmaceutical compound
GB201315733D0 (en) Pharmaceutical compounds